FDA Approves Epizyme Drug Tazverik
A conversation with Epizyme President and CEO Rob Bazemore and Catherine J. Malatesta Foundation Chair Jennifer Goodwin. Her daughter passed away from a rare form of cancer that a newly-FDA-approved drug produced by Epizyme is working to treat.